Annual CFF
$67.13 M
-$25.72 M-27.70%
31 December 2021
Summary:
Concert Pharmaceuticals annual cash flow from financing activities is currently $67.13 million, with the most recent change of -$25.72 million (-27.70%) on 31 December 2021. During the last 3 years, it has fallen by -$25.72 million (-27.70%).CNCE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$21.00 M
-$48.85 M-69.94%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly cash flow from financing activities is currently $21.00 million, with the most recent change of -$48.85 million (-69.94%) on 30 September 2022.CNCE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$155.32 M
+$21.00 M+15.63%
30 September 2022
Summary:
Concert Pharmaceuticals TTM cash flow from financing activities is currently $155.32 million, with the most recent change of +$21.00 million (+15.63%) on 30 September 2022.CNCE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -27.7% | +100.0% | +523.9% |
| 5 y5 years | +10000.0% | +5637.2% | +9972.4% |
CNCE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -27.7% | -74.9% | at high |
Concert Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $21.00 M(-69.9%) | $155.32 M(+15.6%) |
| June 2022 | - | $69.85 M(>+9900.0%) | $134.32 M(+108.4%) |
| Mar 2022 | - | $0.00(-100.0%) | $64.47 M(-4.0%) |
| Dec 2021 | $67.13 M(-27.7%) | $64.47 M(>+9900.0%) | $67.13 M(+169.7%) |
| Sept 2021 | - | $0.00(0.0%) | $24.89 M(-0.1%) |
| June 2021 | - | $0.00(-100.0%) | $24.91 M(-0.4%) |
| Mar 2021 | - | $2.66 M(-88.0%) | $25.02 M(-73.1%) |
| Dec 2020 | $92.85 M(+6299.2%) | $22.23 M(>+9900.0%) | $92.85 M(+31.5%) |
| Sept 2020 | - | $13.00 K(-88.1%) | $70.63 M(-0.5%) |
| June 2020 | - | $109.00 K(-99.8%) | $70.99 M(+1.1%) |
| Mar 2020 | - | $70.50 M(>+9900.0%) | $70.19 M(+4737.7%) |
| Dec 2019 | $1.45 M(-958.6%) | $12.00 K(-96.7%) | $1.45 M(-5.9%) |
| Sept 2019 | - | $366.00 K(-153.7%) | $1.54 M(+28.6%) |
| June 2019 | - | -$682.00 K(-138.9%) | $1.20 M(+30.8%) |
| Mar 2019 | - | $1.75 M(+1603.9%) | $917.00 K(-642.6%) |
| Dec 2018 | -$169.00 K(-103.1%) | $103.00 K(+347.8%) | -$169.00 K(-104.3%) |
| Sept 2018 | - | $23.00 K(-102.4%) | $3.91 M(-115.1%) |
| June 2018 | - | -$964.00 K(-244.1%) | -$25.94 M(-616.8%) |
| Mar 2018 | - | $669.00 K(-84.0%) | $5.02 M(-8.6%) |
| Dec 2017 | $5.49 M | $4.18 M(-114.0%) | $5.49 M(+239.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$29.83 M(-199.4%) | $1.62 M(-94.9%) |
| June 2017 | - | $30.00 M(+2533.6%) | $31.50 M(+1913.9%) |
| Mar 2017 | - | $1.14 M(+269.8%) | $1.56 M(+160.2%) |
| Dec 2016 | $601.00 K(-98.6%) | $308.00 K(+470.4%) | $601.00 K(-421.4%) |
| Sept 2016 | - | $54.00 K(-14.3%) | -$187.00 K(-88.4%) |
| June 2016 | - | $63.00 K(-64.2%) | -$1.62 M(-54.0%) |
| Mar 2016 | - | $176.00 K(-136.7%) | -$3.52 M(-108.5%) |
| Dec 2015 | $41.48 M(-46.8%) | -$480.00 K(-65.2%) | $41.48 M(+3.5%) |
| Sept 2015 | - | -$1.38 M(-25.1%) | $40.08 M(+0.4%) |
| June 2015 | - | -$1.84 M(-104.1%) | $39.92 M(+1.0%) |
| Mar 2015 | - | $45.18 M(-2496.9%) | $39.51 M(-49.3%) |
| Dec 2014 | $77.97 M(-1178.0%) | -$1.89 M(+22.4%) | $77.97 M(+2.7%) |
| Sept 2014 | - | -$1.54 M(-31.4%) | $75.88 M(+0.5%) |
| June 2014 | - | -$2.25 M(-102.7%) | $75.53 M(-1.3%) |
| Mar 2014 | - | $83.64 M(-2206.3%) | $76.49 M(-1157.5%) |
| Dec 2013 | -$7.23 M(-159.4%) | -$3.97 M(+109.6%) | -$7.23 M(+121.7%) |
| Sept 2013 | - | -$1.90 M(+47.6%) | -$3.26 M(+138.6%) |
| June 2013 | - | -$1.28 M(+1447.0%) | -$1.37 M(+1547.0%) |
| Mar 2013 | - | -$83.00 K | -$83.00 K |
| Dec 2012 | $12.17 M(+74.2%) | - | - |
| Dec 2011 | $6.99 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CNCE is $67.13 M
What is the all time high annual CFF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual cash flow from financing activities is $92.85 M
What is Concert Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CNCE is $21.00 M
What is the all time high quarterly CFF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly cash flow from financing activities is $83.64 M
What is Concert Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CNCE is $155.32 M
What is the all time high TTM CFF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM cash flow from financing activities is $155.32 M